3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
CNS
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
6
Uterine Cervical Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Thoracic Neoplasms
1
Thoracic Diseases
1
Spinal Diseases
1
Interventions
pembrolizumab
59
Cisplatin
45
Cetuximab
29
Radiotherapy
26
Carboplatin
24
Docetaxel
17
Paclitaxel
16
Nivolumab
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
Standard of Care
8
tislelizumab
7
cemiplimab
6
atezolizumab
6
Radiation
6
Chemoradiotherapy
6
toripalimab
5
Cyclophosphamide
5
130-nm albumin-bound paclitaxel
5
nimotuzumab
4
fludarabine
4
durvalumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Afatinib
4
palbociclib
3
niraparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Magnetic Resonance Imaging
×
1 year
×
Clear all
NCT07185958
2025-09-22
DART
Aalborg University Hospital
Not yet recruiting
80 enrolled